Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|September 24, 1999
Longevity is independent of common variations in genes associated with cardiovascular riskE M Bladbjerg, K Andersen-Ranberg, M P de Maat, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 14, 2001
Urokinase-type plasminogen activator system predicts risk of cardiovascular events in patients with angina pectoris: results of the ECAPTURE study. European Concerted Action on Prevention from Thrombosis by URokinase EnhancementM P de Maat, G Dooijewaard, P Meijer, et al.
Journal of Thrombosis and Haemostasis : JTH|August 28, 2003
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal womenJ S Madsen, S R Kristensen, J Gram, et al.
Lancet (London, England)|February 18, 1995
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitusB Myrup, P M Hansen, T Jensen, et al.
Ugeskrift for Laeger|January 28, 1991
[Standardized prothrombin time determinations and optimal anticoagulant therapy]J Jespersen, M S Hansen, J Dyerberg, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|April 25, 2007
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosisJ J Sidelmann, J A Sjøland, J Gram, et al.
Medical Mycology|February 6, 2009
Evaluation of three commercial latex agglutination kits and a commercial enzyme immunoassay for the detection of cryptococcal antigenNgolela Esther Babady, Jean E Bestrom, Deborah J Jespersen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 20, 2004
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determinationA M H P van den Besselaar, T W Barrowcliffe, L L Houbouyan-Réveillard, et al.
Pageof 22